C. Lumley

发表

Allergenicity of proteins

D. Metcalfe, I. Kimber, C. Lumley, 1997, Human & experimental toxicology.

Chronic Toxicity Testing: Present Perspectives and the Way toward Shorter Screening, Decreased Use of Resources and Better Risk Assessment

P. H. Bach, P. Grasso, A. Cockburn, 1991 .

The Timing of Toxicological Studies to Support Clinical Trials

S. Walker, N. McAuslane, C. Parkinson, 1994, Springer Netherlands.

A Critical Review of the Optimum Duration of Chronic Rodent Testing for the Determination of Non-Tumourigenic Toxic Potential: A Report by the BTS Working Party on Duration of Toxicity Testing

G. Betton, A. Cockburn, T. Connors, 1994, Human & experimental toxicology.

Suggestions that might be considered for improving the review process

C. Lumley, 1996 .

Improving the Regulatory Review Process

S. Walker, C. Lumley, 1996, CMR Workshop Series.

Prospects for reducing and refining the use of dogs in the regulatory toxicity testing of pharmaceuticals

G. Betton, D. Straughan, R. Combes, 2000, Human & experimental toxicology.

Genotoxicity testing: current practices and strategies used by the pharmaceutical industry.

D. Tweats, C. Harvey, C. Lumley, 1995, Mutagenesis.

Issues Relating to the Release of Proprietary Information and Data for Use in the Validation of Alternative Methods

M Todd, B Garthoff, W Bernhardt, 1998, Alternatives to laboratory animals : ATLA.

Non-clinical safety studies for biotechnologically-derived pharmaceuticals: conclusions from an International Workshop

S. Griffiths, C. Lumley, Cyndy E Lumley, 1998, Human & experimental toxicology.